Trial intelligence / Profile preview

Bioequivalence of Mucinex ER 600 mg vs Guaifenesin IR in Healthy Volunteers

NCT03642262Phase 1Completed

Sponsor
Reckitt
Start
Jun 2013
Primary completion
Aug 2013
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of acetaminophen in cough (2 arms), sponsored by Reckitt. Primary endpoints: Maximum Observed Plasma Concentration and Area Under the Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration. Started Jun 2013; status: completed.

02

Drugs

acetaminophen
03

Conditions

cough

Beyond the preview

Go deeper on NCT03642262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03642262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call